1997/1998 Publications Page |
1997/1998 Publications Page |
Elstein E and Huan C: Polymorphisms for angiotensin converting enzyme, angiotensinogen, nitric oxide synthase and endothelin and their association with cardiac allograft vasculopathy in the first year post transplant. Transplant Proc 29:2575, 1997.
Elstein E and Huan C: Polymorphisms in genes of angiotensin converting enzyme, angiotensinogen, nitric oxide synthase and endothelin and their association with cardiac allograft rejection. Transplant Proc 29:2576, 1997.
Brugada R, Kelsey W, Lechin M, Zhao G, Yu QT, Zoghbi W, Quinones M, Elstein E, et al: Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med 45(9):542-551, 1997.
Levine B for the MACH-1 Investigators Elstein E: The design of the mortality assessment in congestive heart failure trial (MACH-1, Mibefradil). Clin Cardiol 20:320-326, 1997.
Foulkes WD, Buu PN, Filiatrault D, Leclerc J-M and Narod SA: An excess of congenital abnormalities in French-Canadian children with neuroblastoma: A case series study from Montreal. Med Pediatr Oncol 29:272-79, 1997
Foulkes WD, Wong N, Brunet J-S, Narod SA, Bégin LR, Zhang JC, Martinez JJ, Tonin PN, Karp SE, Pollak MN, Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465-2470, 1997
Sun S, Pollock P, Liu L, Karimi P, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA and Foulkes WD: CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein. Int J Cancer 73:531-536, 1997.
Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR and Foulkes WD. A familial non-toxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial non-medullary thyroid cancer. Amer J Hum Genet 61:1123-1130, 1997.
Eeles RA, Durocher F, Simard J, Edwards SM, Badzioch M, Ford D, Dearnaley DP, Arden-Jones A, Dowe A, Shearer R, the CRC/BPG UK Familial Prostate Cancer Study Collaborators, Labrie F, Tonin PN, Easton DF, Narod SA, Foulkes WD. Analysis of the contribution of candidate genes to familial prostate cancer. Br J Urol 79 (1):8-14, 1997.
Eeles RA, Simard J, Teare D, Edwards S, Durocher F, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Arden-Jones A, Dowe A, Shearer R, Ford D, Amos C, The CRC/BPG Familial Prostate Cancer Study Collaborators, Ghadirian P, Aprikian A, Norman R, McLellan D, Labrie F, Narod SA, Easton D and Foulkes W: Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Amer J Hum Genet 62:653-658, 1998.
Gilfix BM and Briones L: Absence of the A1256G mutation in a-antichymotrypsin in a North American population suffering from dementia. J Cerebral Blood Flow Metab 17: 233-235, 1997.
Gilfix BM, Blank DW and Rosenblatt DS: The use of a novel reductant in the determination of total plasma homocysteine. Clin Chem 43: 687-688, 1997.
O’Neil WM, Gilfix BM, DiGirolamo A, Tsoukas CM, Wainer IW. N-acetylation among HIV positive and AIDS patients: when is fast, fast and slow, slow ? Clin Pharmacol Ther 62:261-271, 1997.
Solymoss BC, Bourassa MG, Wesolowska E, Dryda I, Théroux P; Mondor L and Gilfix BM: The role of cardiac tropinin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndrome. Clin Cardiol 20: 934-942, 1997.
Chaour M, Théroux P, Gilfix BM, Campeau L, Lespérance J, Ghitescu M, Gélinas F and Solymoss BC: ‘True’ fasting serum insulin level, insulin resistance syndrome and coronary artery disease. Coronary Artery Disease 8: 683-688, 1997.
Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, Wikstrom J, Palo J, Stein LD, Hudson TJ, Lander ES, and Peltonen L: Genomewide scan of multiple sclerosis in Finnish multiplex families. Amer J Hum Genet 61:1379-1387, 1997.
Rosenberg M, Hui L, Ma J, Nusbaum HC, Clark K, Robinson L, Dziadzio L, Swain PM, Keith T, Hudson TJ, Biesecker LG, and Flint J: Characterization of short tandem repeats from thirty-one human telomeres. Genome Res 7:917-923, 1997.
Xiao S, Lux ML, Reeves R, Hudson TJ, and Fletcher JA: HMGI(Y) activation by chromosome 6p21 rearrangements in mulitilineage mesenchymal cells from pulmonary hamartoma. Amer J Pathol 150:901-910, 1997.
Druker HA, Kasprzak L, Bégin LR, Jothy S, Narod SA, and Foulkes WD: A family with Graves’ disease, multinodular goiter, non-medullary thyroid carcinoma and alveolar rhabdomyosarcoma. Amer J Med Genet 72:30-33, 1997.
Hu J, Bumstead N, Barrow P, Sebastiani G, Olien L, Morgan K and Malo D: Resistance to salmonellosis in the chicken is linked to NRAMP1 and TNC. Genome Res 7:693-704, 1997.
Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B, Mercier J, Poirier J, Capozzoli F, Bouchard J-P, Lemieux B, Mathieu J, Vanasse M, Seni M-H, Graham G, Andermann F, Andermann E, Melançon SB, Keats BJB, Di Donato S and Pandolfo M: Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Annals Neur 41:675-682, 1997.
Simard LR, Rochette C, Séminov A, Morgan K and Vanasse M: SMNT and NAIP mutations in Canadian families with spinal muscular atrophy (SMA): Genotype/phenotype correlations with disease severity. Amer J Med Genet 72:51-58, 1997.
Turecki G, Rouleau GA, Joober R, Mari J and K. Morgan: Schizophrenia and chromosome 6p. Amer J Med Genet (Neuropsychiatric Genetics) 74:195-198, 1997.
Turecki G, Rouleau GA, Mari J, Joober R and Morgan K: Lack of association between bipolar disorder and tyrosine hydroxylase: a meta-analysis. Amer J Med Genet (Neuropsychiatric Genetics) 74:348-352, 1997.
Turecki G, Rouleau GA and Morgan K: Modeling the phenotype in parametric linkage analysis of bipolar disorder. In Genetic Analysis Workshop 10: Detection of Genes for Complex Traits, edited by L.R. Goldin, J.E. Bailey-Wilson, I.B. Borecki, C.T. Falk, A.M. Goldstein, B.K. Suarez, and J.W. MacCluer. Genet Epidemiol 14:687-691, 1997.
Weiler T, Greenberg CR, Nylen E, Morgan K, Fujiwara TM, Crumley MJ, Zelinski T, Halliday W, Nickel B, Triggs-Raine B and Wrogemann K: Limb girdle muscular dystrophy in Manitoba Hutterites does not map to any of the known LGMD loci. Amer J Med Genet 72:363-368, 1997.
Ledley FD and Rosenblatt DS: Mutations in MUT methylmalonic acidemia: clinical and enzymatic correlations. Hum Mut 9:1-6, 1997.
Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest Jr. J and Rozen, R: Correlation of a common mutation in the methylene-tetrahydrofolate reductase (MTHFR) gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 17:569-573, 1997.
Fowler B, Schutgens RBH, Rosenblatt DS, Smit GPA and Lindemans J: Folate-responsive homocystinuria and megaloblastic anemia in a female patient with functional methionine synthase deficiency (cblE disease). J Inherit Met Dis 20:731-741, 1997.
Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, and Seashore MR: Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inher Met Dis 20:528-538, 1997.
Evans MI, Duquette DA, Rinaldo P, Bawle E, Rosenblatt DS, Whitty J, Quintera RA and Johnson MP: Modulation of B12 dosage and response in fetal treatment of methylmalonic aciduria (MMA): titration of treatment dose to serum and urine MMA. Fetal Diagn Ther 12:21-23, 1997.
Gulati S, Chen Z, Brody LC, Rosenblatt DS and Banerjee R: Defects in auxiliary redox proteins lead to functional methionine synthase deficiency. J Biol Chem 272:19171-19175, 1997.
Harding CO, Arnold G, Barness LA, Wolff JA and Rosenblatt DS: Functional methionine synthase deficiency due to cblG disorder: A report of two patients and a review. Amer J Med Genet 71:384-390, 1997.
Steen C, Rosenblatt DS, Scheyng H, Breuer HC and Kohschütter A: Cobalamin E (cblE) disease: a severe neurological disorder with megaloblastic anemia, homocystinuria and low serum methionine. J Inher Metab Dis 20:705-706, 1997.
Howard R, Frieden IJ, Crawford D, McCalmont T, Levy M, Rosenblatt DS, Sweetman L, Goodman SI, Ohnstad C, Hart K, Berrios M and Packman S: Methylmalonic acidemia, cobalamin C type presenting with cutaneous manifestations. Arch Dermatol 133:1563-1566, 1997.
Dubé MP, Mlodzienski M, Kibar Z, Farlow M, Eber G, Harper P, Kolodny E, Rouleau GA, Figlewicz D: Hereditary Spastic Paraplegia: LOD-Score Consideration for Confirmation of Linkage in a Heterogeneous Trait. Amer J Hum Genet 60:625-629, 1997.
Lafreniere R, Rochefort D, Chretien N, Rommens J, Cochius J, Kaliainen R, Nousiainen U, Patry G, Farrell K, Soderfeld B, Federico A, Hale B, Hernandez-Cossio O, Sorensen T, Pouliot M, Kmiec T, Uldall P, Halasz P, Pranzatelli M, Andermann F, Andermann E, Rouleau GA: Unstable Insertion in the 5' Flanking Region of the Cystatin B Gene is the Most Common Mutation in Progressive Myoclonus Epilepsy Type 1 (EPM1). Nat Genet15:298-302, 1997.
Parboosingh J, Figlewicz D, Krizus A, Meininger V, Azad A, Newman D, Rouleau GA: Spinobulbar Muscular Atrophy can Mimic ALS: The Importance of Genetic Testing on Male Patients with Atypical ALS. Neurol 49:568-572, 1997.
Goto J, Watanabe M, Ichikawa Y, Yee S, Ihara N, Endo K, Igarashi S, Takiyama Y, Gaspar C, Maciel P, Tsuji S, Rouleau GA, Kanazawa I: Machado-Joseph Disease Gene Products Carrying Different Carboxyl Termini. Neurosci Res 28:373-377, 1997.
Maciel P, Lopes-Cendes I, Kish S, Sequeiros J, Rouleau GA: Mosaicism of the CAG Repeat in CNS Tissue in Relation to Age at Death in SCA1 and MJD Patients: Is Glia the Source of Mosaicism in CNS? Amer J Hum Genet 60:993-996, 1997.
Turecki G, Rouleau GA, Joober R, Mari J, Morgan K: Schizophrenia and Chromosome 6p. Amer. J Hum Genet 74:348-352, 1997.
Robitaille Y, Lopes-Cendes I, Becher M, Rouleau GA, Clark AW: The Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features. Brain Pathology 7:901-926, 1997.
Claudio J, Veneziale R, Menko S, Rouleau GA: Expression in Schwannomin Lens and Schwann Cells. Neuro Report 8:2025-2030, 1997.
Lopes-Cendes I, Teive H, Calcagnotto M, da Costa J, Cardoso F, Maciel J, Radvany J, Arruda W, Trevisol-Bittencourt P, Neto P, Silveira I, Steiner C, Pinto-Junior W, Santos A, Neto Y, Werneck L, Araujo A., Carakushansky G, Mello L, Jardim L, Rouleau GA: Frequency of the Different Mutations Causing Spinocerebellar Ataxia in a Large Group of Brazilian Patients.Arq Neuropsiquiatr 55:519-529, 1997.
Robitaille Y, Lopes-Cendes I, Becher M, Rouleau GA, Clark AW. The Neuropathology of CAG Repeat diseases: Review and Updated of Genetic and Molecular Features. Brain Pathology 7:901-926, 1997.
Lafreniere R, Kibar Z, Rochefort D, Han FY, Fon E, Dubé M-P, Kang X, Baird S, Korneluk R, Rommens J, Rouleau GA. Genomic Structure of the Human GT334 (EHOC-1) Gene Mapping to 21q22.3. Gene 198:313-32, 1997.
Saino M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E, Lutchman M, Rouleau GA, Jääskeläinen J, Vaheri A, Carpen O. Neurofibromatosis 2 Tumor Suppressor Protein Colocalizes with Ezrin and CD44 and Associates with Actin-containing Cytoskeleton. J Cell Sci 110:2249-2260, 1997.
Lopes-Cendes I, Teive H, Cardoso F, Viana E, Calcagnotto M, da Costa J, Trevisol-Bittencourt P, Maciel J, Rousseau M, Santos A, Araujo A, Rouleau GA: Molecular Characteristics of Machado-Joseph Disease Mutation in 25 Newly Described Brazilian Families. Brazilian J Genet 20:717-724, 1997.
Brais B, Bouchard J.-P., Xie YG, Gosselin F, Fardeau M, Tomé F, Rouleau GA: Using the Full Power of Linkage Analysis in 11 French Canadian Families to Fine Map the Oculopharyngeal Muscular Dystrophy Gene. Neuromuscular Disorders 7:S70-S74, 1997.
Bouchard J.P., Brais B, Brunet D, Gould P, Rouleau GA: Recent Studies on Oculopharyngeal Muscular Dystrophy in Quebec. Neuromuscular Disorders 7:S22-S29, 1997.
Mathieu J, Lapointe G, Brassard A, Tremblay C, Brais B, Rouleau GA, Bouchard JP: A Pilot Study on Upper Oesophageal Sphincter Dilatation for the Treatment of Dysphagia in Patients with Oculopharyngeal Muscular Dystrophy. Neuromuscular Disorders 7:S100-S104, 1997.
Turecki G, Rouleau GA: Mari J, Morgan K: Bipolar Disorder and Tyrosine Hydroxylase: a Meta-Analysis. Amer J Hum Genet 74:348-352, 1997.
Turecki G, Rouleau GA, Morgan K: Modelling the Phenotype in Parametric Linkage Analysis of Biopolar Disorder. Genet Epidemiol 14: 687-691, 1997.
Shinotoh H, Thiessen B, Snow BJ, Hashimoto S, MacLeod P, Silveira I, Rouleau GA, Schulzer M, Calne DB. Fluorodopa and Raclopride PET Analysis of Patients with Machado-Joseph Disease. Neurology 49: 1133-1136, 1997.
Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM, Serova O, and Lynch HT: BRCA2 hereditary cancer pathophenotype. Breast Cancer Research & Treatment 44: 275-277, 1997.
Rahman N, Arbour L, Tonin P, Baruchel S, Pritchard-Jones K, Narod SA, and Stratton MR: The Familial Wilms’ tumour susceptibility gene, FWT1, may not be a tumour suppressor gene. Oncogene 14: 3099-3102, 1997.
Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, and Narod S: A descriptive study of BRCA1 testing and reaction to disclosure test results. Cancer 79:2219-2228, 1997.
Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, and Lenoir GM: Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Amer J Hum Genet. 60: 486-495, 1997.
Karp SE, Tonin PN, Begin LR, Martinez JJ, Zhang JC, Pollack MN, and Foulkes WD: Influence of BRCA1 mutations in nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish Women. Cancer 80: 435-431, 1997.
Liede A, Tonin PN, Sun CC,Serruya C, Baly MB, Narod SA, and Foulkes WD: Is hereditary site-specific ovarian cancer a distinct genetic condition? Amer J Med Genet 75: 55-58, 1997.
Foulkes WD: Inherited susceptibility to squamous cell carcinoma of the head and neck. Ann Cancer Control Res, 1997, 7: pp 492-498.
Foulkes WD, Flanders TY, Pollock PM and Hayward NK: CDKN2A and cancer. Molecular Med, 1997, 3: 4-19.
Zander C, Burgess CE , Johansen J, Linblad K, Hudson TJ, and Schalling M: RED - Repeat Expansion Detection. Graham R. Taylor (Ed.): Detection of DNA Sequence Polymorphisms and Mutations: Methods and Applications, 1997, pp. 263-271.
Shevell MI, Cooper BA and Rosenblatt DS: Inherited disorders of cobalamin and folate transport and metabolism, in The Molecular and Genetic Basis of Neurological Disease, R.N. Rosenberg, S.B. Prusiner, S. DiMauro and R.L. Barchi (eds.) 2nd edition, Butterworth-Heinemann, USA 1997, pp 1301-1321.
Whitehead VM, Rosenblatt DS and Cooper BA: Megaloblastic Anemia in Infants and Children, in Hematology of Infancy and Childhood. D.G. Nathan and F.A. Oski (eds.) 5th edition, W.B. Saunders Co., 1997, pp 385-422.
Rosenblatt DS: Inherited Disorders of Folate and Cobalamin. I.H. Rosenberg, in Homocysteine Metabolism: From Basic Science to Clinical Medicine. I. Graham, P. Ueland, H. Refsum (eds.) Kluwer Academic Publishers, Netherland 1997, pp 61-68.
Christensen B and Rosenblatt DS: The roles of folate and vitamin B12 in the central nervous system: lessons from inborn errors, in Epilepsy and other Neurological Disorders in Coeliac Disease. G. Gobbi, F. Andermann, S. Naccarato, G. Banchini (eds.) John Libbey Co., 1997, pp 39-45.
Bourgault C, Elstein E, Lelorier J and Suissa S: Adequacy of reference-pricing: Assessing equivalence of economic outcomes of ACE inhibitors. 13th International Conference on Pharmacoepidemiology. April 1997.
Cantarovich M, Besner JG, Barkun J, Elstein E, Fitchett D et al. Cyclosporine 2- hour peak level: a new tool for neoral dose monitoring. The American Society of Transplant Physicians Annual Scientific Meeting. May 10-14, 1997.
Elstein E and Elstein J: Adequacy of Beta blockade in chronic stable angina. Fourth International Conference on Preventive Cardiology. June 29 - July 3, 1997.
Elstein E and Kassarjian A: ACE genotype in sporadic hypertrophic cardiomyopathy. Fourth International Conference on Preventive Cardiology. June 29 - July 3, 1997.
Elstein E and Huan C: Polymorphisms of the renin angiotensin system genes and vasoactive system genes in heart failure. Fourth International Conference on Preventive Cardiology. June 29 - July 3, 1997.
Provencher D, Godard B, Foulkes WD, Brunet J-S, Tonin PN, Mes-Masson, A-M, Drouin P, Dubuc-Lissoir J, Gauthier P, Audet-Lapointe P, Narod SA and Ghadirian P: Risk factors for familial and sporadic ovarian cancer among French-Canadians: a case-control study. La Société des Obstétricians et Gynécologues du Canada, 1997.
Eeles R, Simard J, Teare D, Edwards S, Easton D, Dearnaley D, Durocher F, Shearer R, Ardern-Jones A, Dowe A, 105 Collaborators (UK), Narod S and Foulkes W. Does the hereditary prostate cancer gene, HPC1, contribute to a large proportion of familial prostate cancer? Br J Cancer supplement, 1997.
Pal T, Flanders T, Narod SA, Foulkes W: Implications of Double primary cancers of the colon and endometrium. Presented at Terry Fox Workshop on Cancer Genetics, Canadian Collaborative Group for Cancer Genetics, Toronto, May 31-June 1 1997. Abstract Poster #20.
Brunet J-S, Foulkes WD, Tonin P, Ghadirian P, Narod SA: Screening for Hereditary Breast cancer. Presented at Terry Fox Workshop on Cancer Genetics, Canadian Collaborative Group for Cancer Genetics, Toronto, May 31-June 1 1997. Abstract Poster #5.
Wainer IW, O'Neil WM, Gilfix BM, DiGirolamo A and Tsoukas CM: The effect of HIV-related disease progression on N-acetyltransferase 2 activity. 163rd Annual Meeting of the American Association for the Advancement of Science, Seattle, February 1997.
Bergeron J, Mallet L, Huang A and Gilfix BM: Case report of homozygous CYP2D6 deficiency and polypharmacy in an elderly woman. American Geriatrics Society & American Federation For Aging Research, p 117, May 7-11,1997
Graham G, Treacy E, Gilfix BM, Phommarinh K, Rozen R, Seni M and Andermann E: The influence of VPA and CBZ monotherapy on homocysteine metabolism in women of childbearing age: role in teratogenesis ? International Congress of Epilepsy Jun 28 -July 4, 1997.
Bayley TM, Jones PJH, Bulani J, Wykes L, Gilfix BM, Krug-Wispe S, Alasmi M, Thorkelson T and Tsang RC: Association between apolipoprotein E phenotype and endogenous cholesterol synthesis in breast-and formula-fed enfants. Experimental Biology April 6-9, 1997.
Rhode BM, Shustik C, Gilfix BM, Christou NV and MacLean LD: Iron absorption and therapy after gastric bypass. Second International Congress of Obesity Surgery, 1997.
Mallet L, Bergeron J, Huang A and Gilfix BM: Déficience en CYP2D6 et polypharmacie chez une personne âgée: présentation d’un cas. La Société Québécoise de Gériatrie XIIIe Congrès Scientifique Annuel, 29 et 30 mai 1997.
Hudson TJ, Stein K, Nusbaum C, Birren B, Wang D, Korenberg J, Shuler G, Boguski M, Weissenbach J, Chee M, Fan J, Ghandour G, Sapolsky R, Lipshutz R, and Lander E: An STS-based map of the human genome. Poster presentation at the Burroughs Welcome Fund 1997 Career Awards Meeting, July 24-26, 1997, Chateau Montebello, Quebec.
Hudson T, Stein L, Lander E, Bútard C, Morgan K, Gaudet D, and Mathieu J: Human genome maps: tools for disease gene identification. Clin Invest Med 20(4): 1997.
Galvez M, Hendy GN, Kremer R, Kasprzak L, Wing S, Dougan S, Mulligan LM, and Rosenblatt DS: Novel point mutation in exon 13 of the RET gene in two families with familial medullary thyroid carcinoma (FMTC). Sixth International Workshop on Multiple Endocrine Neoplasia. June 25-28, 1997, Noordwijkerhout, Netherlands, poster presentation #337.
Hudson T, Stein L, Lander E, Bétard C, Morgan K, Gaudet D and Mathieu J: Human genome maps: tools for disease gene identification. Clin Invest Med 20(4): 1997.
Franzmann TL, Greenberg CR, Illarioshkin SN, Ivanova-Smolenskaya IA, Morgan K, Weiler T, Nylen E and Wrogemann K: Searching for modifier gene(s) in limb girdle muscular dystrophy type 2B and Miyoshi myopathy. Amer J Hum Genet 61:A275, 1997.
Giguére Y, Dodin S, Blanchet C, Dumont M, Morgan K and Rousseau F: Common polymorphisms in vitamin D receptor and estrogen receptor in the prediction of bone mineral density and stiffness index in a cohort of postmenopausal women. Amer J Hum Genet 61:A199, 1997.
Mulders SM, Bichet DG, PlL J. Rijss, Kamsteeg E-J, Arthus M-F, Lonergan M, Fujiwara M, Morgan K, van Os CH and Deen PMT: An AQP2 mutant encoded in dominantly-inherited nephrogenic diabetes insipidus is impaired in its routing from a post-endoplasmic reticulum compartment. Molecular Biol Cell 8:305a, 1997.
Rousseau F, Morel ML, Levesque S, Dombrowski S and Morgan K: Instability of FMR1 grey-zone and premutation-size alleles identified by screening in the general population. Amer J Hum Genet 61:A319, 1997.
Adjalla CE, Hosack AR, Gilfix BM, Sun S, Evans S, Matiaszuk NV and Rosenblatt DS: Mutations in mut methylmalonic aciduria. Seventh International Congress of Inborn Errors of Metabolism. May 21-25, 1997. Vienna, Austria.
Sniderman LC, Lambert M, Giguère R, Rosenblatt DS, Auray-Blais C, Lemieux B, Scriver CR, Laframboise R and Treacy E: Outcome of patients with low-moderate methylmalonic aciduria in Quebec. Amer J Hum Genet 61:A261, 1997.
Christensen B, Arbour L, Tran P, Sabbaghian N, Platt R, Gilfix B, Rosenblatt DS, Forbes P, and Rozen R: Relation between the C677T polymorphism in the MTHFR gene, the folate levels in red blood cells, and risk for neural tube defects. Amer J Hum Genet 61:A150, 1997.
Wilson A, Leclerc D, Saberi F, Phillips JA, Pfotenhauer JP, Rosenblatt DS and Gravel RA: Causal mutations in siblings with the cblG variant from the methionine synthase deficiency. Amer J Hum Genet 61:A263, 1997.
Wong N, Brunet JS, Narod S, Begin LR, Zhang JZ, Martinez JJ, Tonin P, Karp KE, Pollak MN and Foulkes WD: Germline BRCA1 mutation is an adverse prognostic factor in Asheknazi Jewish women with breast cancer. Terry Fox Workshop: Canadian Collaborative Group for Cancer Genetics, Toronto, Ontario. 1997.
Tonin PN, Mes-Masson A-M, Provencher D, Foulkes WD, Simard J, Narod SA and Ghadirian P: Mutation analysis of BRCA1 and BRCA2 in hereditary breast-ovarian cancer families of French-Canadian descent. Terry Fox Workshop: Canadian Collaborative Group for Cancer Genetics, Toronto, Ontario. 1997.
Ghadirian P, Narod S, Brunet J-S, Tonin P, Mes-Masson A-M, Provencher D and Goddard B: Epidemiology of family history of cancer: reproductive factors and medical history of ovarian cancer in French-Canadians. Ovarian Cancer: Prevention, Genetics, and Treatment Challenges, Toronto, Ontario. 1997.
Liede A, Sun CC, Narod SA, Tonin PN, Serruya C, Foulkes WD and Daly MB: Is hereditary site-specific ovarian cancer a distinct genetic entity? Ovarian Cancer: Prevention, Genetics, and Treatment Challenges, Toronto, Ontario. 1997.
Wang J-C, Lagousakos N, Bielanska MM, Mes-Masson A-M, Tonin P, Provencher D and Eydoux P: Characterization of a novel chromosome rearrangement with fluorescence in situ hybridization in a cell line from an ovarian epithelial carcinoma. Ovarian Cancer: Prevention, Genetics, and Treatment Challenges, Toronto, Ontario. 1997.
Wang J-C, Lagousakos N, Bielanska MM, Mes-Masson A-M, Tonin P, Provencher D and Eydoux P: Characterization of a clonal chromosome rearrangement using fluorescence in situ hybridization in a cell line from an ovarian epithelial carcinoma. Am J Hum Genet 61:A366, 1997.
Wong N, Brunet J-S, Begin LR, Wang JC, Martinez JJ, Tonin PN, Narod SA, Karp SE, Pollack MN and Foulkes WD: Germ-line BRCA1 mutations is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Amer J Hum Genet 61:A89, 1997.
Rahman N, Arbour L, Tonin PN, Schwartz C, Narod SA, Pritchard-Jones K and Stratton MR: Characterization of the familial Wilms tumour gene FWT1. Amer J Hum Genet 61:A79, 1997.
Gilfix BM, Blank DW and Rosenblatt DS: Novel reductant of total plasma homocysteine. Clin. Chem. 43:687-688, 1997. (Technical Briefs).
Rosenblatt DS: Genetic analysis in the methylmalonic acidurias. Organic Acidemia Association Newsletter. VII (3):6, 1997.
Brunet S-B, Narod SA, Tonin P, and Foulkes WD: Re: Survival rates in BRCA1 carriers with ovarian cancer. [Comment on N Engl Med 335: 1413, 1996]. N Engl J Med 336: 1256, 1997. (Letter).
(c)1998 PMNowacki Ent(r)
for Finestone Laboratory
